Moolec Science (MLEC)
NASDAQ:MLEC
Want to see MLEC full AI Analyst Report?
MLEC Stock Chart & Stats
$4.11
-$0.04(-4.25%)
At close: 4:00 PM EST
$4.11
-$0.04(-4.25%)
Day’s Range― - ―
52-Week Range$3.08 - $157.06
Previous CloseN/A
Volume11.69K
Average Volume (3M)209.37K
Market Cap
$5.87M
Enterprise Value$252.36M
Total Cash (Recent Filing)$1.93M
Total Debt (Recent Filing)$22.09M
Price to Earnings (P/E)―
Beta-0.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding726,118
10 Day Avg. Volume506,476
30 Day Avg. Volume209,369
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.62
Price to Sales (P/S)0.12
P/FCF Ratio-1.35
Enterprise Value/Market Cap42.96
Enterprise Value/Revenue32.22
Enterprise Value/Gross Profit-394.62
Enterprise Value/Ebitda-48.41
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Commercialization TractionA dramatic revenue ramp and materially higher gross margin indicate the company is successfully converting engineered crop traits into ingredient sales. This suggests product-market fit and scalable unit economics as volumes increase, supporting sustainable revenue growth and future commercialization leverage.
New Controlling Shareholder / Capital SupportA single majority investor materially strengthens the capital base and strategic alignment, reducing immediate refinancing risk. Committed ownership can provide patient funding, accelerate scale-up of cultivation and processing, and improve execution certainty over the coming quarters.
Governance & Operations Expertise AddedAdding an operations and quality veteran to key committees enhances industrial-quality discipline and regulatory oversight. Stronger governance and operational controls are durable enablers for scaling agricultural biotech manufacturing, reducing execution risk and improving regulatory readiness.
Bears Say
Negative Equity & High DebtSubstantially negative equity combined with large outstanding debt weakens the balance sheet and elevates refinancing and solvency risk. This structural leverage limits financial flexibility, increases the likelihood of dilutive capital raises, and may constrain investments needed for long-term commercialization.
Ongoing Cash BurnPersistent negative operating and free cash flow show the business does not yet generate self-sustaining cash. Continued burn requires external funding to support R&D, regulatory work, and scale-up, making strategic plans contingent on new capital or committed investor support over the medium term.
Conditional Nasdaq Listing / Compliance RiskA conditional listing underscores prior compliance and reporting issues and imposes near-term remediation milestones. The need to meet governance and disclosure conditions diverts management focus and risks loss of US market access, potentially forcing urgent, dilutive financings or operational concessions.
Moolec Science News
MLEC FAQ
What was Moolec Science’s price range in the past 12 months?
Moolec Science lowest stock price was $3.08 and its highest was $157.06 in the past 12 months.
What is Moolec Science’s market cap?
Moolec Science’s market cap is $5.87M.
When is Moolec Science’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Moolec Science’s earnings last quarter?
Currently, no data Available
Is Moolec Science overvalued?
According to Wall Street analysts Moolec Science’s price is currently Overvalued.
Does Moolec Science pay dividends?
Moolec Science does not currently pay dividends.
What is Moolec Science’s EPS estimate?
Moolec Science’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Moolec Science have?
Moolec Science has 726,118 shares outstanding.
What happened to Moolec Science’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Moolec Science?
Currently, no hedge funds are holding shares in MLEC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Moolec Science
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Technical Analysis
AIM ImmunoTech
―
Ensysce Biosciences
―
Cyclerion Therapeutics
―
―
Calidi Biotherapeutics
―
Ownership Overview
―
Insiders
0.01% Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---